In the present study, our data for the first time revealed that MN could ameliorate the cognitive deficits in TgCRND8 transgenic mice via inhibition of neuroinflammation and synaptic dysfunction through modulating the PI3K/Akt/GSK-3β and NF-κB pathways. The gene discussed is NFKB1; the disease is Cognitive impairment.